[Edaily Reporter PARK MIN ] #Oncocross Co.,Ltd. announced on the 30th that it had signed a contract with Omics AI Co., Ltd. to outsource proteomics analysis services as part of its Digital Biobanking (DBB) business and efforts to build AI-based medical data assets.
The contract covers the pretreatment of test samples, protein identification and quantification via mass spectrometry, data interpretation and statistical analysis, and the provision of results reports and raw data.
The contract value represents more than 10% of the company’s projected 2025 revenue of 370.46 million won. A 50% down payment will be made on the 31st, a 25% interim payment on October 30, and the remaining 25% on December 31.
The contract period runs from the 1st of this month through December 31. A company official stated, “As this outsourcing contract pertains to business operations, the contract amount and specific terms will not be disclosed in accordance with the agreement between the two companies.”
The contract covers the pretreatment of test samples, protein identification and quantification via mass spectrometry, data interpretation and statistical analysis, and the provision of results reports and raw data.
The contract value represents more than 10% of the company’s projected 2025 revenue of 370.46 million won. A 50% down payment will be made on the 31st, a 25% interim payment on October 30, and the remaining 25% on December 31.
The contract period runs from the 1st of this month through December 31. A company official stated, “As this outsourcing contract pertains to business operations, the contract amount and specific terms will not be disclosed in accordance with the agreement between the two companies.”
